Aeglea BioTherapeutics, Inc. Uncategorized Contracts & Agreements

50 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated September 20, 2024, by and between the Company and Sheldon Sloan
Aeglea BioTherapeutics, Inc.
Biotechnology
PA
2024
Fifth Amendment to the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
2024
Second Amended and Restated Antibody Discovery and Option Agreement, dated May 14, 2024, by and between the Company, Paragon Therapeutics, Inc. and Parapyre Holding LLC
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2024
Amendment No. 1 to
Aeglea BioTherapeutics, Inc.
Biotechnology
2024
Offer Letter, dated August 18, 2023, by and between the Company and Heidy King-Jones
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2024
Offer Letter, dated August 1
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2024
Spyre Therapeutics, Inc
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2024
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
Biotechnology
2024
Amended and Restated Offer Letter, dated November 22, 2023 and as amended on February 1, 2024, by and between the Company and Cameron Turtle
Aeglea BioTherapeutics, Inc.
Biotechnology
WA
2024
Amendment to the Amended and Restated Letter Agreement by and between the Company and Cameron Turtle, dated as of February 1, 2024
Aeglea BioTherapeutics, Inc.
Biotechnology
2024
Offer Letter, dated August 10, 2023, by and between the Company and Scott Burrows
Aeglea BioTherapeutics, Inc.
Biotechnology
CA
2023
Spyre Therapeutics, Inc. 2018 Equity Inducement Plan and the First Amendment, Second Amendment, Third Amendment and Fourth Amendment thereto
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2023
Amended and Restated Antibody Discovery and Option agreement, dated September 29, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, LLC
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2023
Amended and Restated Offer Letter, dated November 22, 2023, by and between the Company and Cameron Turtle
Aeglea BioTherapeutics, Inc.
Biotechnology
WA
2023
Novation Agreement, dated September 19, 2023, by and between Paragon Therapeutics, Inc., the Company and WuXi Biologics (Hong Kong) Limited
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2023
Form of Pre-Funded Warrants 2022
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2023
Amended and restated letter agreement by and between the Company and Cameron Turtle, dated as of November 22, 2023
Aeglea BioTherapeutics, Inc.
Biotechnology
WA
2023
Offer Letter, dated August 10, 2023, by and between the Company and Scott Burrows
Aeglea BioTherapeutics, Inc.
Biotechnology
CA
2023
Third Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
2023
2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2023
Offer Letter, dated June 22, 2023, by and between Aeglea BioTherapeutics, Inc. and Cameron Turtle
Aeglea BioTherapeutics, Inc.
Biotechnology
CA
2023
Form of Pre-Funded Warrants 2022
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2023
Second Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
2023
Amended and Restated Antibody Discovery and Option agreement, dated September 29, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, LLC
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2023
Novation Agreement, dated September 19, 2023, by and between Paragon Therapeutics, Inc., Aeglea BioTherapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2023
Offer Letter by and between the Company and Scott Burrows, dated as of August 10, 2023
Aeglea BioTherapeutics, Inc.
Biotechnology
CA
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
Biotechnology
2023
Antibody Discovery and Option agreement, dated May 25, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, Inc
Aeglea BioTherapeutics, Inc.
Biotechnology
MA
2023
Offer Letter, dated June 22, 2023, by and between Aeglea BioTherapeutics, Inc. and Cameron Turtle
Aeglea BioTherapeutics, Inc.
Biotechnology
CA
2023
Offer Letter, dated June 14, 2021 issued by the Registrant to Mr. Jonathan Alspaugh
Aeglea BioTherapeutics, Inc.
Biotechnology
2022
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
Biotechnology
2021
Offer letter, dated March 13, 2020 issued by the Registrant to Dr. Leslie Sloan
Aeglea BioTherapeutics, Inc.
Biotechnology
2020
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
Biotechnology
2020
Offer Letter, dated July 18, 2018 by and between the Company and Anthony G. Quinn
Aeglea BioTherapeutics, Inc.
Biotechnology
2018
Offer Letter, dated June 20, 2017, issued by the Registrant to Dr. James Wooldridge
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2018
Offer Letter, dated August 31, 2017, issued by the Registrant to Dr. Anthony Quinn
Aeglea BioTherapeutics, Inc.
Biotechnology
2017
Terms of Resignation between the Registrant and Dr. David G. Lowe
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017
Offer Letter, dated April 21, 2017, issued by the Registrant to Dr. Anthony Quinn
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017
Exhibit a
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017